AI technologies aim to overcome geographical disparities in accessing advanced prostate cancer treatments like abiraterone, which reduces mortality risks. This initiative targets systemic healthcare inequities, potentially impacting patient survival rates across regions in the UK. The research leverages predictive algorithms for personalized treatment guidance.
💊 AI Breakthrough in Prostate Cancer Drug Access
